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Abstract 
Background: It is important to understand whether the potential impact of pyrethroid resistance on malaria control 
can be mitigated by switching between different pyrethroids or whether cross-resistance within this insecticide class 
precludes this approach.
Methods: Here we assess the relationships among pyrethroids in terms of their binding affinity to, and depletion 
by, key cytochrome P450 enzymes (hereafter P450s) that are known to confer metabolic pyrethroid resistance in 
Anopheles gambiae (s.l.) and An. funestus, in order to identify which pyrethroids may diverge from the others in their 
vulnerability to resistance. We then investigate whether these same pyrethroids also diverge from the others in terms 
of resistance in vector populations.
Results: We found that the type I and II pyrethroids permethrin and deltamethrin, respectively, are closely related in 
terms of binding affinity to key P450s, depletion by P450s and resistance within vector populations. Bifenthrin, which 
lacks the common structural moiety of most pyrethroids, diverged from the other pyrethroids tested in terms of both 
binding affinity to key P450s and depletion by P450s, but resistance to bifenthrin has rarely been tested in vector 
populations and was not analysed here. Etofenprox, which also lacks the common structural moiety of most pyrethroids, 
diverged from the more commonly deployed pyrethroids in terms of binding affinity to key P450s and resistance in vec-
tor populations, but did not diverge from these pyrethroids in terms of depletion by the P450s. The analysis of depletion 
by the P450s indicated that etofenprox may be more vulnerable to metabolic resistance mechanisms in vector popula-
tions. In addition, greater resistance to etofenprox was found across Aedes aegypti populations, but greater resistance 
to this compound was not found in any of the malaria vector species analysed. The results for pyrethroid depletion by 
anopheline P450s in the laboratory were largely not repeated in the findings for resistance in malaria vector populations.
Conclusion:  Importantly, the prevalence of resistance to the pyrethroids α-cypermethrin, cyfluthrin, deltamethrin, 
λ-cyhalothrin and permethrin was correlated across malaria vector populations, and switching between these com-
pounds as a tool to mitigate against pyrethroid resistance is not advised without strong evidence supporting a true 
difference in resistance.
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Introduction
The primary malaria control intervention in high-burden 
countries is the deployment of long-lasting insecticide-
treated nets (LLINs) impregnated with pyrethroids, 
alone or in combination with a second active ingredient 
or synergist [1, 2]. Widespread and increasing resistance 
to pyrethroids is, therefore, a serious potential threat to 
malaria control [3, 4]. Because the options for LLINs are 
limited, it is essential to understand whether the impact 
of resistance can be mitigated by switching between dif-
ferent pyrethroids or whether cross-resistance within this 
insecticide class precludes this approach. ‘Cross-resist-
ance’ often refers to the instance where resistance is con-
ferred to two or more classes of insecticide, is commonly 
assumed within an insecticide class. Evidence for diver-
gence in resistance within an insecticide class may, how-
ever, be relevant especially given the reliance on a single 
insecticide class, the pyrethroids. Pyrethroids listed by 
the World Health Organization (WHO) for malaria 
control are differentiated into two groups based on bio-
logical activity that is associated with the absence (type 
I) or presence (type II) of an alpha-cyano group (Fig. 1). 
Type II pyrethroids are more lethal to insects because of 
their higher potency to the voltage-gated sodium chan-
nel (VGSC) in nerve membranes, the primary target site 
of pyrethroids [5, 6]. The higher potency of type II pyre-
throids, such as deltamethrin and α-cypermethrin, trans-
lates into much lower doses being required to treat vector 
control products compared with type I pyrethroids, such 
as permethrin. This has led to increased deployment of 
alpha-cyano pyrethroids, in particular α-cypermethrin, 
which is currently used in 28% of the prequalified vec-
tor control products [2]. Generally, the pyrethroids used 
in vector control possess the common structural motif 
of phenoxybenzyl alcohol coupled with a cyclopropane 
ring via an ester bond, except for bifenthrin and etofen-
prox (Fig. 1). This narrow spectrum of chemical variation 
among pyrethroids makes it likely that cross-resistance 
will occur in malaria vector populations.
The high-burden countries where LLINs are deployed 
are concentrated in Africa where the most important vec-
tors are Anopheles gambiae (s.l.) and Anopheles funestus 
[7]. Pyrethroid resistance in malaria vectors is primarily 
associated with target-site insensitivity due to mutations 
in the Vgsc gene known as knockdown resistance (kdr) 
and increased detoxification activity known as metabolic 
resistance. Metabolic mechanisms of resistance are found 
in all African malaria vectors, whereas kdr mutations 
are common in species of the Anopheles gambiae com-
plex but not in the An. funestus subgroup [8–14]. There 
are multiple amino acid substitutions that cause target-
site insensitivity resulting in pyrethroid resistance [15]. 
This includes a mutation, M918T, that produces a super-
knockdown (s-kdr) phenotype in houseflies. Structure 
modelling studies in M918T phenotypes indicate that the 
highest degree of resistance in s-kdr houseflies depends 
on the chemical structure of the insecticide, which is 
positively correlated with the presence of an α-cyano 
Fig. 1 Chemical structure of pyrethroid insecticides used for malaria vector control. The common scaffold of pyrethroids, boxed in red, was 
identified by searching 230 million compounds available in the ZINC database (https ://zinc.docki ng.org)
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group coupled with a phenoxybenzyl moiety in the larger 
type II pyrethroid molecules, such as deltamethrin and 
fenvalerate [16]. By comparison, the most common Vgsc 
resistance allele in west African An. gambiae populations, 
L1014F, is not influenced by pyrethroid chemical struc-
ture when expressed alone in house flies [17].
Although kdr mutations are common in An. gam-
biae (s.l.), they may have a relatively modest impact on 
resistance, and they are absent from highly pyrethroid-
resistant An. funestus populations, suggesting that meta-
bolic mechanisms may have a greater impact in African 
malaria vectors [18–20]. Metabolic resistance is most 
commonly mediated by elevated levels of cytochrome 
P450 (CYP) enzymes (hereafter referred to as P450s) 
[21]. Transcriptome-wide studies of gene expression in 
resistant and susceptible mosquito strains have found 
that upregulation of several cytochrome P450 genes is 
associated with resistance to both a type I pyrethroid 
(permethrin) and a type II pyrethroid (deltamethrin). For 
example, upregulation of the CYP6P3 gene and its ortho-
logues CYP6P9a and CYP6P9b and of the CYP6AA1, 
CYP6Z1 and CYP6Z3 genes is associated with resist-
ance to both of these pyrethroids in An. gambiae/An. 
coluzzii and An. funestus [22–32]. In addition, upregula-
tion of the CYP6Z2 gene in An. gambiae and An. coluzzii, 
and of the CYP6M7 gene in An. funestus, is also associ-
ated with resistance to both pyrethroids [23–25, 27, 28, 
30–32]. These findings from studies of gene expression 
in resistant and susceptible strains provide evidence for 
P450-mediated pyrethroid cross-resistance in Anoph-
eles populations, particularly to deltamethrin and per-
methrin; however, associations among resistance to more 
than one pyrethroid have not always been found, a lim-
ited range of pyrethroids has been tested and these stud-
ies do not give an indication of whether cross-resistance 
is stronger between some pyrethroids than others. Like 
the Anopheles vectors, target-site mutations and meta-
bolic resistance are also thought to be the main resistance 
mechanisms in Aedes mosquitoes [33, 34].
An assessment of the impact of individual structural 
variation within the pyrethroid class on resistance in 
the field is required to inform the best use of different 
compounds. A previous study assessed resistance in 
malaria vector populations at more than 1000 sites in 
Africa and showed that when spatio-temporal trends 
were separated from noise in the susceptibility test 
data, strong associations among the resistance trends 
for three structurally similar pyrethroids (deltame-
thrin, ʎ-cyhalothrin and permethrin) were found [35]. 
The variance in the mean percent mortality values was 
28 for the west Africa model and 23 for the east Africa 
model, reflecting the noisiness of the mortality data. 
This study also noted that the prevalence of resistance 
to permethrin was typically higher than that to del-
tamethrin; however, caution is needed when interpret-
ing differences found using susceptibility test data 
because they may be due to real differences in the prev-
alence of resistance or differences in the calibration of 
the diagnostic dose, or both. Diagnostic doses currently 
recommended for use were calculated by doubling the 
dose of a compound which kills 100% of a susceptible 
strain of a species, or doubling the  LC99 (lethal con-
centration that incurs 99% mortality) in this strain [36, 
37]. A robust recommendation should be based on data 
from multiple strains in different testing centres, but 
where this is not possible doses may not be well cali-
brated between compounds. It is clear that differences 
in resistance between individual pyrethroids cannot 
be generally assumed, but it remains unclear whether 
meaningful differences can occur, particularly when a 
wider range of pyrethroid chemistries is considered.
In the study reported here, we took a new approach 
to assess variation in resistance among pyrethroids. 
We first assessed differences in pyrethroid chemistry 
that influence inhibition of the key enzymes that con-
fer metabolic resistance in African malaria vectors, 
and the rate of depletion of each pyrethroid by these 
enzymes [38]. Of the primary resistance genes, the 
P450 superfamily is most frequently associated with 
metabolic resistance to pyrethroids in malaria vectors. 
Therefore, we assessed the relative differences among 
six pyrethroids in terms of their molecular interactions 
with P450s from the major African malaria vectors by 
constructing a P450s structure–activity relationship 
model (P450s-SAR). We focussed on α-cypermethrin, 
deltamethrin and permethrin as most relevant for rec-
ommendations regarding the current LLIN options. 
However, for broader future consideration, we included 
bifenthrin, etofenprox, cyfluthrin and λ-cyhalothrin, 
all structurally varied pyrethroids that are also in the 
WHO’s prequalified list for malaria vector control 
(Fig. 1) [2]. We then analysed resistance to these pyre-
throids in multiple vector populations to determine 
whether the relative differences found by P450s-SAR 
studies translated into relative differences in resistance 
within wild populations. This was supplemented by an 
analysis of resistance in arbovirus vector populations. 
Finally, the resistance associations found across insecti-
cide classes were also analysed in order to put the rela-
tionships found within the pyrethroids into the wider 
context of cross-resistance generally and to further 
investigate whether cross-resistance predicted by labo-
ratory studies can be detected as general trends in the 
field data.
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Material and methods
In order to test whether relationships identified by SAR 
studies can be detected in the field, we constructed den-
drograms for the hierarchical relationships between 
pyrethroids found by a series of molecular and field stud-
ies, and then compared the dendrograms obtained.
Relationships among pyrethroids in terms of functional 
activity data
Cytochrome P450 inhibition assays using fluorogenic 
probe substrates have become commonplace in drug 
discovery screening cascades and are a rapid method 
of screening for insecticide interactions with mos-
quito P450s to predict insecticide binding, metabo-
lism, cross-resistance and synergism [38–41]. In this 
study, the half maximal inhibitory concentration  (IC50), 
which provides a value for inhibition of each P450 by 
each pyrethroid (also referred to as ‘binding affin-
ity’), and the percentage depletion, which gives a value 
for metabolism of each pyrethroid by each P450 (also 
referred to as vulnerability to metabolic attack), were 
both included as parameters to establish a P450s struc-
tural activity relationship model. This model was used 
to understand both the chemistry of the pyrethroids 
and the interaction with mosquito P450s that function 
as monooxygenases in metabolic resistance, to predict 
cross-resistance liabilities in  vivo. A low  IC50 value 
indicates that the pyrethroid being assessed is a potent 
inhibitor that may be able to counter resistance medi-
ated by P450s. A low percentage depletion indicates 
low metabolism of the pyrethroid, which means that it 
may be less vulnerable to resistance mediated by P450s.
The  IC50 values for permethrin, etofenprox and bifen-
thrin (type I) and deltamethrin, λ-cyhalothrin and 
α-cypermethrin (type II) pyrethroids that were exposed 
to recombinant P450s from the An. gambiae Kisumu 
strain (CYP6Z2, =6M2, -6P2, -6P3 and -9J5) and the 
An. funestus FUMOZ strain (CYP6P9a) were extracted 
from two studies [38, 41]. In addition, inhibition activ-
ity data for these pyrethroids exposed to CYP6Z3 from 
the An. gambiae Kisumu strain were also generated 
(Additional file 1).
The values for percentage depletion (metabolism) 
of each pyrethroid by three of the enzymes CYP6M2, 
CYP6P3 and CYP6P9a, which were expressed in a sin-
gle plasmid construct, were also extracted from the 
same sources and used for the comparative analysis.
The two datasets were analysed using hierarchical 
clustering of rows (insecticide) and columns (P450) 
by Perseus v1.6.14.0 to produce two visual heat maps 
representing the clustered matrices for relative insec-
ticide binding affinity and insecticide vulnerability to 
metabolic attack. The clustered matrices for functional 
activity data for these six pyrethroids against these 
seven P450s were then used to construct dendro-
grams for the hierarchical relationships among the 
pyrethroids.
Relationships among pyrethroids in terms of susceptibility 
test mortality in malaria vector populations
We accessed a published database of insecticide resist-
ance in African malaria vectors [14] and identified all 
instances in which a mosquito sample from the field 
had been tested using two or more pyrethroids. Pairs of 
results were extracted, rather than instances in which a 
sample had been divided between tests of three or more 
pyrethroids, because there were insufficient data from 
studies testing > 2 pyrethroids against a single mos-
quito collection. Each data point provided paired sus-
ceptibility test data from a single collection sampled at 
a given time and place that was subdivided and subse-
quently tested under identical experimental conditions, 
with the aim  of addressing the question ‘for a given 
time, place, species/complex and method, does higher 
resistance to pyrethroid A indicate higher resistance to 
pyrethroid B?’. A total of 3153 pairs of WHO suscepti-
bility test results from samples of the An. gambiae com-
plex were obtained. Only data that detected resistance 
to at least one pyrethroid were included; that is, results 
from samples that demonstrated 100% mortality to all 
of the pyrethroids tested were excluded.
We conducted a series of correlation analyses to assess 
how closely associated each pair of pyrethroids is in 
terms of resistance. The mean value for the Pearson’s 
correlation coefficient was calculated across 1000 boot-
strapped samples for each pyrethroid pair using SPSS 
Statistics v25 (IBM Corp., Armonk, NY, USA). A Holm-
Bonferroni correction was applied to identify significant 
correlations among the multiple tests conducted while 
avoiding false positives [42]. The mean correlation coef-
ficients generated were ranked to identify the most and 
least closely correlated pyrethroids, respectively. These 
bootstrap mean correlation coefficients were used to 
construct a dendrogram of the hierarchical relationships 
among pyrethroids using the unweighted pair-group 
method with arithmetic mean [43], where the highest 
correlation coefficient indicated the most closely related 
pair.
The analyses conducted using data from An. gambiae 
(s.l.) samples were repeated using data from the An. 
funestus subgroup, An. arabiensis, An. coluzzii, An. funes-
tus and An. gambiae samples (Additional file 2). The same 
approach was also used for susceptibility test data from 
Aedes albopictus and Ae. aegypti to investigate whether 
the same relationships could be detected in these vectors 
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of arboviruses, as detailed in Additional file 3. There were 
much lower data volumes for the individual Anopheles 
species, compared to An. gambiae (s.l.), and a limited 
selection of pyrethroid pairs could be tested so no den-
drograms were constructed from these data. Finally, the 
correlations between resistance to deltamethrin and 
resistance to insecticides from other classes were calcu-
lated in order to put the relationships found within the 
pyrethroids into the broader context of cross-resistance.
Results
Relationships among pyrethroids in terms of functional 
activity data
The six pyrethroids were categorised according to their 
inhibition of diethoxyfluorescein metabolism by P450s as 
potent  (IC50 < 1 μM), moderate  (IC50 1–10 μM) and weak 
inhibitors  (IC50 > 10 μM) [44]. Accordingly, all pyre-
throids investigated showed low to moderate binding to 
the P450 panel (Fig. 2a; Additional file 1: Table S2). Bifen-
thrin had the lowest binding to the P450s panel examined 
(Fig. 2a; Additional file 1: Table S2).
CYP6P3, -6M2 and -6P9a were selected for compara-
tive metabolism analysis because they are commonly 
associated with pyrethroid resistance, are among the 
earliest pyrethroid resistance markers to be functionally 
validated and are most heavily used for in vitro screening 
[29, 41, 45, 46]. All of the pyrethroids, with the excep-
tion of bifenthrin, were strongly metabolised by CYP6P3 
and its orthologue CYP6P9a expressed from An. gam-
biae and An. funestus, respectively (Fig.  2b; Additional 
file  1: Table  S3). However, lower metabolism profiles 
were observed with CYP6M2 expressed from An. gam-
biae (Fig. 2b; Additional file 1: Table S3). Notably, etofen-
prox was strongly metabolised by CYP6P3, CYP6M2 and 
CYP6P9a. Overall, the metabolism data presented in 
Fig. 2b and Additional file 1: Table S3 ranked etofenprox, 
deltamethrin and permethrin as the most vulnerable 
insecticides for metabolic attack by the three enzymes, 
followed by α-cypermethrin and ʎ-cyhalothrin; bifen-
thrin demonstrated the lowest vulnerability.
The dendrograms indicate that, in terms of inhibition 
of P450s and metabolism by P450s, permethrin and del-
tamethrin are closely related whereas bifenthrin diverges 
from these pyrethroids, (Fig. 2).
Relationships among pyrethroids in terms of susceptibility 
test mortality in malaria vector populations
Each of the 15 pairs of values for pyrethroid resist-
ance within An. gambiae (s.l.) was significantly cor-
related (Table  1). That is, populations with a higher 
prevalence of resistance to one pyrethroid tended to have 
a higher prevalence of resistance to the others (Fig.  3; 
Fig. 2 Cluster analysis of functional activity data for six pyrethroids against cytochrome P450 (CYP) enyzmes (P450s) from African malaria vectors. a 
Inhibition data from the screening of six pyrethroids (scaffold structures indicated on the right of data panels) against a set of P450s are presented 
as a heat map. Target enzymes are arrayed along the x-axis, and each of the pyrethroids is arrayed along the y-axis. Colours indicate the inhibition 
potency of pyrethroids with an indicated variable scaffold for a designated target P450. Potent (hot) inhibitors are assigned a red colour, and 
weak or ineffective (cold) inhibitors are given a light-green colour. b Pyrethroid metabolism by the P450s most widely associated with resistance 
from Anopheles gambiae (CYP6M2 and CYP6P3) and An. funestus (CYP6P9a) is clustered and presented as a heat map. Pyrethroids susceptible to 
metabolism are assigned a red colour, and weak metabolism is denoted light green. Dendrograms were obtained by hierarchical clustering and 
indicate the degree of similarity as a function of the height of the lines connecting the profiles
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Additional file  2: Figure S2). The pyrethroid pairs were 
ranked from the most closely correlated pair, deltame-
thrin versus λ-cyhalothrin, to the most divergent pair, 
etofenprox versus λ-cyhalothrin (Table  1; Fig.  4a). The 
correlation coefficients were used to construct a den-
drogram of the hierarchical relationships among these 
pyrethroids (Fig.  4b). Deltamethrin, λ-cyhalothrin, per-
methrin, cyfluthrin and α-cypermethrin were closely 
related whereas etofenprox diverged from the other five 
pyrethroids.
Comparison of pyrethroid relationships seen 
in the molecular and field studies
The three dendrograms using data for (i) resistance in 
field populations, (ii) P450 inhibition and (iii) depletion 
by P450s were re-constructed incorporating only the 
five pyrethroids that were included in all three analy-
ses (Fig.  5). The dendrograms for P450 inhibition (also 
referred to as binding affinity) and vector population 
resistance both show that deltamethrin, λ-cyhalothrin, 
permethrin are most closely related to each other, fol-
lowed by α-cypermethrin, with etofenprox as the most 
divergent (Fig. 5a, b). The dendrogram constructed using 
values for insecticide depletion (also referred to as vul-
nerability to metabolic attack) by CYP6P3, CYP6M2 and 
CYP6P9a reveals different relationships among these 
pyrethroids, although permethrin and deltamethrin are 
still closely related (Fig. 5c).
Correlations in pyrethroid resistance within malaria vector 
species
Across An. funestus subgroup communities, there were 
significant correlations between resistance to deltame-
thrin and λ-cyhalothrin, permethrin and λ-cyhalothrin, 
and deltamethrin and permethrin, and the same was true 
for the four species tested (Table 2; Additional file 2: Fig-
ures S3 and S4). There were insufficient data to test the 
other pyrethroid combinations for the African malaria 
vector species. Across Ae. aegypti populations, resistance 
to cyfluthrin, deltamethrin, λ-cyhalothrin and perme-
thrin was significantly correlated, whereas there were no 
Table 1 Correlations in resistance to seven pyrethroids in the 
Anopheles gambiae complex
 r, Pearson’s correlation coefficient
*Significant results (at the 0.05 level with a Holm-Bonferroni correction) 
a The most closely correlated pair is ranked first
Rank Pyrethroid  paira Paired sample 
size (N)
Mean r
1 Deltamethrin vs λ-cyhalothrin 597 0.774*
2 Permethrin vs cyfluthrin 62 0.752*
3 Permethrin  vs λ-cyhalothrin 484 0.729*
4 Deltamethrinvs permethrin 1278 0.726*
5 α-Cypermethrin vs cyfluthrin 27 0.709*
6 Deltamethrin vs α-cypermethrin 242 0.684*
7 Deltamethrin vs cyfluthrin 64 0.675*
8 Permethrin vs α-cypermethrin 197 0.671*
9 λ-Cyhalothrin vs α-cypermethrin 154 0.573*
10 Permethrin vs etofenprox 68 0.567*
11 Deltamethrin vs etofenprox 80 0.549*
12 α-Cypermethrin vs etofenprox 42 0.507*
13 Etofenprox vs cyfluthrin 20 0.476*
14 λ-Cyhalothrin vs cyfluthrin 54 0.467*
15 λ-Cyhalothrin vs etofenprox 63 0.418*
Fig. 3 Distributions of values for three example pyrethroid pairs. a The most closely related pyrethroid pair in terms of resistance in wild mosquito 
populations (deltamethrin and λ-cyhalothrin), b a mid-ranked pyrethroid pair (permethrin and α-cypermethrin), c the least closely related 
pyrethroid pair (λ-cyhalothrin and etofenprox). Each point represents the results from a single An. gambiae (s.l.) sample that was subdivided 
between two susceptibility tests. The plots for all pairs are shown in Additional file 2: Figure S2
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significant correlations between these four pyrethroids 
and etofenprox (full results are given in Additional file 3).
In order to put the relationships found within the 
pyrethroids into the wider context of cross-resistance 
across the insecticide classes used for malaria vector 
control, the correlations between deltamethrin and 
six commonly used non-pyrethroid insecticides were 
also calculated. Significant correlations with the preva-
lence of resistance to dichlorodiphenyltrichloroethane 
(DDT) were found for species within the An. gambiae 
complex but not for An. funestus (Additional file  2: 
Table  S4, Figure S5). No significant correlations were 
found between the prevalence of resistance to del-
tamethrin and that to bendiocarb or propoxur (carba-
mates), malathion, fenitrothion or pirimiphos-methyl 
(organophosphates) for species within the An. gambiae 
complex or An. funestus.
Fig. 4 Relationships among pyrethroids defined by correlations in resistance within An. gambiae complex mosquitoes. a The mean correlation 
coefficient for each pyrethroid pair ranked from the most closely correlated to the most divergent. alph. α-Cypermethrin, cyfl. cyfluthrin, delt. 
deltamethrin, etof. etofenprox, lamb. λ-cyhalothrin, per. permethrin. The bars represent the upper and lower 95% bootstrap confidence interval and 
the sample size for each pair is given below these bars. b The hierarchical relationships among pyrethroids defined using the correlation coefficients 
shown in a 
Fig. 5 Hierarchical relationships among pyrethroids defined using data on resistance in vectors and functional activity data. The dendrograms were 
constructed using correlations in mortality across African malaria vector populations (Pearson’s correlation coefficient) (a), binding affinity values 
 (IC50) (b) and insecticide depletion values (%) (c)
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Variation in pyrethroid resistance within populations 
of African malaria vector species
The results presented above show significant correla-
tions in resistance among the pyrethroids tested, but this 
result does not preclude the possibility that the preva-
lence of resistance is generally higher in one pyrethroid 
compared to the others across populations with differing 
levels of pyrethroid resistance. The insecticide depletion 
data presented above indicates that some pyrethroids are 
potentially more vulnerable to P450 attack; this is par-
ticularly the case for etofenprox which was most depleted 
by the three P450s (Additional file 1: Table S3). This leads 
to the question of whether higher levels of resistance to 
this compound can be detected in wild mosquito popu-
lations. An analysis of the paired data from An. gambiae 
(s.l.) samples collected across Africa provides no evidence 
that the prevalence of resistance is consistently higher 
for etofenprox compared to the other pyrethroids in An. 
gambiae (s.l.) (Additional file 2: Figure S6), but mortality 
was significantly lower after Ae. aegypti populations were 
exposed to etofenprox compared to mortality following 
exposure to deltamethrin, cyfluthrin, λ-cyhalothrin and 
permethrin (Additional file 3: Table S7).
To put the mortality differences found among pyre-
throids (Additional file 2: Figures S7–S8) into the wider 
context of cross-resistance, the prevalence of resistance 
to deltamethrin was compared to the prevalence of resist-
ance to six non-pyrethroid insecticides in paired suscep-
tibility tests (Additional file  2: Figure S9). A reversal in 
the differences between resistance to deltamethrin and 
to the organochlorine DDT was found, with An. gam-
biae (s.l.) species having significantly higher resistance 
to DDT whereas An. funestus had significantly higher 
resistance to deltamethrin. In all species tested, mortal-
ity was lower following deltamethrin exposure compared 
to exposure to bendiocarb and propoxur (carbamates), 
malathion, fenitrothion and pirimiphos-methyl (organo-
phosphates), respectively.
Discussion
The results of this study highlight which of the pyre-
throids used in malaria control are closely related in 
terms of inhibition of and depletion by P450s. Other 
studies of structurally diverse pyrethroids have also 
shown variation in P450 metabolism of pyrethroids with 
different structures. An in vivo study of the An. funestus 
strain, FUMOZ-R, which is characterised by upregulated 
P450 levels without any target-site mutations, found that 
transfluthrin, which contains a polyfluorobenzyl alcohol, 
was effective in the absence of the generic P450 inhibi-
tor, piperonyl butoxide (PBO), whereas the other pyre-
throids that contain the common phenoxybenzyl moiety, 
including cypermethrin, ß-cyfluthrin, deltamethrin and 
permethrin, were only effective when partnered with 
PBO [47]. This effect was associated with an inability of 
detoxifying enzymes to bind to the uncommon structure 
of transfluthrin. A similar observation was reported ear-
lier from agriculture studies where an isogenic metabolic 
resistance strain isolated from a pyrethroid-resistant field 
population of Helicoverpa armigera showed significant 
cross-resistance between pyrethroids characterised by 
having both the phenoxybenzyl and aromatic acid moie-
ties whereas the substitution of the phenoxybenzyl group 
with a polyfluorobenzyl group, as occurs in tefluthrin, 
benfluthrin and transfluthrin, overcame most of this 
resistance [48]. These studies support the aim of identify-
ing pyrethroids that are active against resistant popula-
tions when P450-mediated resistance plays a major role. 
In our study, bifenthrin diverged from the other pyre-
throids in terms of both inhibition of, and depletion by, 
P450s, but no susceptibility test data were available for 
resistance to bifenthrin in populations of African malaria 
vectors. Susceptibility test data were available for etofen-
prox, and this pyrethroid was found to diverge from the 
Table 2. Correlations between resistance to different 
pyrethroids in African malaria vector species.
 n.s., non-significant results (at the 0.05 level with a Holm-Bonferroni correction)
*Significant results (at the 0.05 level with a Holm-Bonferroni correction)
a Anopheles coluzzii/gambiae refers to mosquito samples that were 
undifferentiated between An. coluzzii (M form) and An. gambiae (S form), before 
they were recognised as two species




 Anopheles funestus subgroup 46 0.818*
 Anopheles funestus 24 0.865*
 Anopheles arabiensis 28 0.946*
 Anopheles coluzzii 18 0.863*
 Anopheles coluzzii/gambiaea 19 0.603*
 Anopheles gambiae 19 0.418 n.s.
Permethrin vs λ-cyhalothrin
 Anopheles funestus subgroup 26 0.786*
 Anopheles funestus 16 0.845*
 Anopheles arabiensis 31 0.859*
 Anopheles coluzzii 14 0.740*
 Anopheles coluzzii/gambiaea 17 0.790*
 Anopheles gambiae 4 Not tested
Deltamethrin vs permethrin
 Anopheles funestus subgroup 113 0.608*
 Anopheles funestus 69 0.726*
 Anopheles arabiensis 116 0.840*
 Anopheles coluzzii 48 0.793*
 Anopheles coluzzii/gambiaea 63 0.714*
 Anopheles gambiae 75 0.782*
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more commonly deployed pyrethroids in terms of inhi-
bition of An. gambiae and An. funestus P450s and in 
terms of resistance in An. gambiae (s.l.) and Ae. aegypti 
populations.
The susceptibility test data from these popula-
tions show strong associations between resistance to 
the most commonly used pyrethroids (deltamethrin, 
λ-cyhalothrin, permethrin and α-cypermethrin), in 
agreement with the results for binding affinity and with 
earlier studies of spatio-temporal trends in An. gambiae 
(s.l.) [3, 35]. The correlations in resistance among these 
pyrethroids, which were demonstrated in all the major 
African malaria vectors, suggest that if differences in 
resistance to these pyrethroids (as well as to the less com-
monly deployed cyfluthrin) are found using susceptibil-
ity tests conducted on a small number of field samples 
of malaria vectors, further evidence should be obtained 
before any decision is made to switch between them.
Greater differentiation was found for resistance to 
bifenthrin in terms of both inhibition of, and deple-
tion by, P450s. The results for bifenthrin are interesting 
because they show that (i) this pyrethroid differs from the 
other pyrethroids in terms of P450 binding and metabo-
lism and that (ii) it may be less susceptible to common 
P450 enzymes. Bifenthrin is the active ingredient in one 
indoor residual spray (IRS), Bistar 10WP [2, 49], which 
is used in India. Bifenthrin IRS was trialled in Nigeria in 
2006 and Zambia in 2011 [50–52], but it has not been 
widely deployed in Africa where concerns about the 
duration of residual activity have been raised [52–54]. 
There are no field data from susceptibility tests on Afri-
can malaria vectors conducted using bifenthrin, pre-
sumably because this compound is rarely deployed and 
because there is no recommended diagnostic dose for use 
in a susceptibility test. One study of Anopheles sinensis in 
Korea collected blood-fed adults in the field and exposed 
subsets of the F1 larvae to each of the pyrethroids con-
sidered in our study. Resistance ratios using  LC50 values 
were calculated from a susceptible strain, and the results 
revealed that the larvae were most susceptible to bifen-
thrin, cyfluthrin and etofenprox, in that order, and least 
susceptible to permethrin [55]. Further evidence comes 
from studies of Aedes vectors, including three studies 
that tested bifenthrin [34]. One study in Mexico tested 
seven populations of Aedes aegypti with eight pyre-
throids and compared the concentrations required for 
50% knockdown  (KC50) and mortality  (LC50) to the same 
values obtained using a susceptible strain to give a resist-
ance ratio (RR) [56]. Across the seven populations, resist-
ance to deltamethrin, lambda-cyhalothrin, permethrin 
and α-cypermethrin were highly correlated (in terms of 
both  RRKC50 and  RRLC50), indicating the existence of 
strong cross-resistance. However, the resistance values 
for bifenthrin were not correlated with any of those for 
the other four compounds, and the authors of the study 
concluded that bifenthrin could be an alternative insecti-
cide for Ae. aegypti in Mexico. Two independent studies 
in Thailand tested three Ae. aegypti and three Ae. albop-
ictus populations, respectively, and calculated the diag-
nostic doses for each pyrethroid, including bifenthrin, 
using a susceptible strain [57, 58]. In both studies, the 
population with the highest deltamethrin resistance also 
had the highest bifenthrin resistance, so no evidence for 
divergence in resistance was observed for these two spe-
cies in Thailand. Given the known data noise in suscep-
tibility test results, caution is needed when interpreting 
the results from a single study at a small number of sites. 
It is also worth noting that bifenthrin’s relative immu-
nity to depletion by CYP6M2, CYP6P3 and CYP6P9a 
described here was not found when tested previously 
[28]. Metabolism assays carried out in two earlier stud-
ies showed that CYP6M7, CYP6P9a and CYP6P9b from 
An. funestus metabolised bifenthrin (62, 68 and 71%, 
respectively) as well as permethrin, deltamethrin and 
λ-cyhalothrin (ranging from 46 to 81% depletion). Field 
tests for bifenthrin resistance in malaria vector popula-
tions are needed before a firm conclusion can be reached 
on whether bifenthrin can be recommended in situations 
where resistance to other pyrethroids has been found.
The analyses of binding affinity data and of field data 
from malaria vector populations both show that resist-
ance to etofenprox diverges, to a degree, from resistance 
to the more commonly deployed pyrethroids. This result 
is backed up by data from studies of resistance in Ae. 
aegypti. However, the depletion activity data suggest that 
etofenprox is more vulnerable to P450 metabolism and 
that if resistance to this compound is found to be greater 
in malaria vector populations, then a switch would not be 
advised. A trend for higher resistance to etofenprox was 
not seen in the data from malaria vector populations but 
it was found in the data from Ae. aegypti populations, 
although caution is needed when interpreting differences 
found using susceptibility test data (particularly tests 
using diagnostic doses that have not been calibrated for 
Aedes species [34]). Etofenprox is the active ingredient in 
two WHO prequalified products, namely a kit for insec-
ticide-treated nets (Vectron 10EW) and an IRS formula-
tion (Vectron20WP) [2]. The latter product is listed by 
the Global Fund, but etofenprox is not widely deployed in 
Africa and was last reported as the active ingredient used 
for IRS in 2012 in parts of Zambia [51, 52].
We found some variation in the relationships among 
pyrethroids when different types of evidence were con-
sidered. In particular, the results for insecticide depletion 
were largely not repeated in the findings for resistance in 
mosquito populations. The results for both insecticide 
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inhibition and insecticide depletion depend on which 
enzymes are included in the activity tests. Seven P450s 
(three for the depletion analysis) were included in the 
present study, whereas at least 14 have been implicated 
in An. gambiae (s.l.) and An. funestus resistance to date 
[21, 22, 24–32, 46, 59–73] and many more in Aedes vec-
tors [34]. It is also important to note that detoxification 
by P450s is not the only mechanism of resistance found 
in these vector species. Target-site mutations are com-
mon in many of these species [9–13], upregulation of 
other detoxifying enzymes is also linked to pyrethroid 
resistance [74] and there is some evidence for cuticular 
thickening in resistant mosquitoes [75]. Upregulation of 
the GSTE2 gene is associated with resistance to both per-
methrin and deltamethrin, as well as DDT, in An. gam-
biae and An. coluzzii [70, 72, 76], An. funestus [29, 71, 74] 
and Ae. aegypti [77–79], and allele frequencies for target-
site mutations in the voltage-gated sodium channel gene, 
Vgsc, have been shown to be useful partial predictors of 
resistance in An. gambiae (s.l.) [35]. Thus, we would not 
expect the findings from molecular studies of P450 activ-
ity alone to be exactly replicated in field populations, 
except in instances where P450-mediated metabolic 
resistance dominates in a mosquito population.
The results for pyrethroid cross-resistance within 
individual species reported here match our knowledge 
of other mechanisms of resistance found in these spe-
cies. Mutations in the Vgsc gene (kdr mutations) confer 
cross-resistance to pyrethroids and DDT, and are par-
tial predictors of patterns of resistance to these com-
pounds in the An. gambiae complex, but they have not 
been found in An. funestus or other members of the An. 
funestus subgroup [3, 8–14, 35]. In our study, correlations 
between pyrethroid and DDT resistance were found for 
members of the An. gambiae complex but not for the 
An. funestus subgroup or species. No correlations were 
found between pyrethroid resistance and resistance to 
the carbamates or organochlorines, underlining the find-
ing that it is cross-resistance within the pyrethroids, as 
well as between the pyrethroids and DDT, that is most 
important. Some metabolic resistance mechanisms do 
confer cross-class resistance, for example between the 
pyrethroids and DDT and/or the carbamates [24, 30, 32, 
73], but the impact of these mechanisms within the array 
of resistance types that co-occur is more nuanced, and 
no cross-class resistance other than the aforementioned 
pyrethroid–DDT resistance in An. gambiae (s.l.) was 
detected here.
In conclusion, we have shown that the type I and type 
II pyrethroids permethrin and deltamethrin, respectively, 
are closely related, as exemplified by (i) the close asso-
ciations between the binding affinities of permethrin and 
deltamethrin to a range of anopheline P450s, (ii) the close 
associations between depletion of permethrin and del-
tamethrin by these P450s and (iii) correlations in resist-
ance to permethrin and deltamethrin in populations of 
An. arabiensis, An. coluzzii, An. gambiae and An. funestus. 
Importantly, a population with higher resistance to one 
of the pyrethroids incorporating the common structural 
motif of phenoxybenzyl alcohol coupled with a cyclo-
propane ring (the primary target for metabolic oxida-
tion) is likely to have higher resistance to the others, and 
these cross-resistance trends could be detected despite 
the noise in the susceptibility test data. It is unlikely that 
resistance to those pyrethroids most commonly deployed 
for malaria control diverges within vector populations, 
and it would be unwise to switch between these com-
pounds based on the results from a small number of sus-
ceptibility tests alone. There are, however, pyrethroids 
that are not commonly deployed that show greater poten-
tial for true divergence in resistance, such as bifenthrin 
and possibly etofenprox. Bifenthrin diverged from the 
other pyrethroids tested in terms of both binding affin-
ity to key P450s and depletion by P450s, but resistance 
to bifenthrin has rarely been tested in vector populations 
and was not analysed here. Etofenprox diverged from the 
more commonly deployed pyrethroids in terms of binding 
affinity to key P450s and resistance in vector populations, 
but was closely related to these pyrethroids in terms of 
depletion by anopheline P450s in the laboratory. The anal-
ysis of pyrethroid depletion by the P450s indicates that 
etofenprox may be particularly vulnerable to metabolic 
resistance mechanisms in vector populations. In addition, 
greater resistance was found across Ae. aegypti popula-
tions, but greater resistance to etofenprox was not found 
in any of the malaria vector species analysed. It is worth 
noting that there are still significant correlations between 
resistance in malaria vector populations to etofenprox and 
resistance to the pyrethroids in common use, and it is pos-
sible that a correlation could also be found for bifenthrin 
once data from multiple vector populations are available 
to answer this question. Systematic SAR analyses of these 
more structurally diverse pyrethroids are required to esti-
mate the effect of structural diversity on pyrethroid resist-
ance, and these findings need to be verified by studies of 
resistance in wild populations.
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